Stay updated with breaking news from Sciences Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced separate collaborations with...
With U.S. stock markets set to open in two hours, (EXAS) was up 8.1% in pre-market trading, and (PARAA) was up 3.2%. (COIN), (MFC), and (BEPC) were all...
Exact Sciences Corp (NASDAQ: EXAS) shares are trading higher Wednesday after the cancer screening and diagnostics company said its Cologuard test demonstrated 94% sensitivity for
ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero
Exact Sciences Co. (NASDAQ:EXAS – Get Rating)’s stock price gapped up before the market opened on Wednesday . The stock had previously closed at $94.34, but opened at $99.00. Exact Sciences shares last traded at $96.19, with a volume of 820,975 shares. Wall Street Analysts Forecast Growth Several research analysts have recently weighed in on […]